Is a synthetic analogue of gonadotropin-releasing hormone (gnrh).
Treatment of prostate cancer (advanced or hormonedependent)
Treatment of endometriosis
Treatment of uterine fibroids (leiomyomata)
Treatment of precocious puberty
Assisted reproductive technologies (in combination with other medications)
Pamorelin La 22.5mg Inj (Triptorelin) acts by initially stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. However, with continued use, it causes a downregulation of GnRH receptors, leading to a suppression of LH and FSH secretion. This suppression results in decreased production of sex hormones (testosterone in men, estrogen in women), which is the therapeutic effect in many of its applications.
Store Triptorelin at a temperature between 2°C and 8°C (36°F and 46°F). Protect from light and freezing. Discard any unused portion according to your doctor's instructions.
Dosage and administration vary greatly depending on the specific condition being treated and the patient's individual needs. Always follow your doctor's prescription instructions precisely.
Triptorelin is typically administered by injection, either subcutaneously (under the skin) or intramuscularly (into a muscle).
The frequency of injections may range from daily to monthly, depending on the prescription.
Hot flashes
Headaches
Mood changes (depression, anxiety)
Decreased libido
Bone loss (osteoporosis – longterm risk)
Vaginal dryness (in women)
Impotence or erectile dysfunction (in men)
Weight changes
Nausea
Alcohol consumption may exacerbate some side effects, such as mood changes. Consult your doctor.
Triptorelin may cause drowsiness or dizziness in some individuals. Avoid driving or operating machinery if affected.
Triptorelin is contraindicated during pregnancy and breastfeeding. Inform your doctor immediately if you are pregnant, plan to become pregnant, or are breastfeeding.
Use in children is only indicated for specific conditions (precocious puberty) and should be under strict medical supervision.
Renal impairment may affect the elimination of Triptorelin. Dosage adjustments may be necessary.
Hepatic impairment may affect the metabolism of Triptorelin. Dosage adjustments may be necessary.
Your doctor or pharmacist
The prescribing information provided with your medication
Reputable medical websites such as the FDA or your national equivalent.
